BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

BioElectronics Corporation's Temple University Diabetic Foot Ulcer Study Published in the International Wound Journal


9/27/2011 8:38:49 AM

FREDERICK, MD--(Marketwire - September 27, 2011) -

BioElectronics Corporation (PINKSHEETS: BIEL) (OTCQB: BIEL), the maker of inexpensive, disposable drug-free topical pain and healing devices, today announced the publication of an article in the International Wound Journal that outlines the effective use of BioElectronics Corporation Pulsed Radio Frequency Energy (PRFE) therapy to successfully treat diabetic and venous stasis ulcers.

"We are very pleased to be able to present this data to the medical field as we believe that our technology could contribute significantly in helping patients suffering from chronic wounds," commented Ian Rawe, PhD, principal author of the article. "The cost of health continues to increase and the treatment of diabetic ulcers runs into the billions of dollars annually. With our innovative products we are able to positively impact, not only the suffering, but also the health care costs involved in the treatment of chronic wounds."

Arnon Horev, VP Sales and Marketing of BioElectronics, commented, "This study on chronic wounds clearly demonstrates something we have known for a very long time. Our technology changes the game for wound healing. Not only are our devices effective in speeding healing and reducing levels of pain, it is also wearable, which makes it a viable solution to alleviate chronic body aches and pains. We plan to use the data from this study to further enhance our international marketing and future applications with the US FDA."

The article, titled, "The use of a portable, wearable form of pulsed radio frequency electromagnetic energy device for the healing of recalcitrant ulcers: a case report." can be viewed at: http://www.ncbi.nlm.nih.gov/pubmed/21933346.

About BioElectronics Corporation

BioElectronics is an award winning medical device developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal complaints, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care to reduce soft tissue pain and swelling. For more information, please see www.bielcorp.com.


Contact:
Ben Fichter
BioElectronics, Inc.
(301) 874-4890

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->